Project Grant R01AR086687
- Federal Project Grant Award Summary Kaiser Foundation Hospitals (Kaiser Permanente) received a $418,224 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), awarded March 1, 2026, with completion scheduled for February 29, 2028. This research project will identify composite medication adherence trajectories in older patients (ages 50-99) living with HIV and multiple chronic conditions, including Type 2 Diabetes Mellitus,...
- Federal Project Grant Summary Kaiser Foundation Hospitals (Kaiser Permanente), through its Kaiser Foundation Research Institute, received a $743,492 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 5, 2025, with completion scheduled for June 30, 2029. The grant funds a longitudinal cohort study examining the effects of HIV pre-exposure prophylaxis (PrEP), specifically tenofovir-based...
- Federal Project Grant Award Summary Kaiser Foundation Hospitals (Kaiser Permanente) received a $2,495,163 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) beginning September 15, 2025, with completion targeted for June 30, 2030. This R01 research project, "Missed Home Health Care in Older Adults with Dementia: Identifying Drivers, Outcomes, and Costs," delivers a comprehensive mixed-methods research initiative designed to identify key...
- Federal Project Grant Award Summary Award Overview Kaiser Foundation Hospitals (Kaiser Permanente) received a $3.92M Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 27, 2025, with completion targeted for August 31, 2029. The HIDDEN-ASCVD (Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of Atherosclerotic...
- Federal Grant Award Summary Kaiser Foundation Hospitals, operating as Kaiser Permanente through its Kaiser Foundation Research Institute, received a $657,841 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award was obligated on August 4, 2025, with a projected completion date of July 31, 2030. The research will be conducted in Pasadena,...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $117,426 Project Grant to the University of California, San Diego, effective June 18, 2026, with completion by May 31, 2028. Under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), this award funds the development of a novel ultrashort echo time quantitative magnetization transfer (UTE-QMT) magnetic resonance imaging (MRI) method...
- Federal Project Grant Award Summary This Project Grant, awarded July 15, 2025, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $169,344 in federal funding to the University of California, Davis through June 30, 2030. The award supports mechanistic research investigating systemic and local immunomodulation of fracture healing in polytrauma patients, addressing a...
- Federal Grant Award Summary Kaiser Foundation Hospitals, operating through its Kaiser Permanente division, received a $370,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period April 1, 2026 through March 31, 2027. The research focuses on establishing evidence-based targets for continuous glucose monitoring (CGM) metrics in adults with...
- Federal Grant Award Summary Kaiser Foundation Hospitals' Kaiser Permanente division received an $880,855 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 12, 2025 through August 31, 2028. The award funds the Ho'okele study, a pilot research initiative designed to develop and test a family-based diabetes self-management education...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Johns Hopkins University a Project Grant of $176,040, effective September 1, 2025, through August 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research project addresses critical diagnostic and genetic gaps in cystic fibrosis (CF)-related osteoporosis by identifying genetic modifiers and developing improved...
Kaiser Foundation Hospitals (Kaiser Permanente) received a $663,216 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective July 1, 2026 through June 30, 2031. The research project will examine bone and muscle properties associated with fracture risk among persons living with Human Immunodeficiency Virus (HIV) infection. The primary deliverable is an improved clinical framework for identifying HIV-positive individuals at highest risk of bone fractures, enabling targeted osteoporosis treatment and reducing fracture-related morbidity in this vulnerable population. The project leverages Kaiser Permanente Southern California's HIV registry and electronic health records to compare bone, muscle, and body composition characteristics between HIV-positive and HIV-negative individuals aged 40 and older. Using novel biomechanical computed tomography analysis methods (BCT+) on existing imaging scans, the research will evaluate how alternative bone quality and muscle measurements—beyond standard bone mineral density assessments—improve fracture prediction. By establishing 1:1 matched cohorts stratified by sex, race/ethnicity, and age, the deliverables will include comparative analyses of bone and muscle metrics and predictive models to refine osteoporosis treatment identification protocols specific to the HIV-positive population.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $663.2k | 6/19/26 |